Cardiol: Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors

Study at a Glance

Estimated Time Commitment

60 Days, inpatient procedures on Day 1, 3, 5, 7; outpatient visits on Day 14, 21 and 28

Eligibility

Adults Hospitalized for COVID but not in ICU.

Diagnosis Required

COVID Pneumonia

Diseases Being Studied

COVID
Location: University Hospital

Clinical Trials.gov identifier NCT04615949

Meet Your Clinical Research Team

Contact us

Principal Investigator: Jan Patterson, M.D., M.S.

Due to requirement for hospitalization at University Hospital, we will not be openly recruiting for the study.